(Q60727685)

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

The dexamethasone suppression test for melancholia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Growth hormone and other responses to clonidine in patients with endogenous depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Interaction between Norepinephrine and Serotonin in the Neuroendocrine Control of Growth Hormone Release in the Rat*

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Pathophysiology of "cholinoceptor supersensitivity" in affective disorders

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Responses of growth hormone to desipramine in endogenous and non-endogenous depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Psychiatric sequelae of chronic exposure to organophosphorus insecticides

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Dose dependent inhibition of REM sleep in normal volunteers by biperiden, a muscarinic antagonist.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

A cholinergic-adrenergic hypothesis of mania and depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Effects of neonatal treatment with monosodium glutamate on growth hormone release induced by clonidine and prostaglandin E1 in conscious male rats

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

The role of the cholinergic pathway in growth hormone feedback

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Growth hormone-releasing factor stimulation test in depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Electroencephalographic sleep profiles in recurrent depression. A longitudinal investigation.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Desipramine and growth hormone secretion

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Effect of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--I. Growth hormone

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Growth hormone (GH) responses to GH-releasing hormone in depression: correlation with GH release following clonidine.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Growth hormone (GH) response to GH-releasing hormone in depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Growth hormone release after desipramine in depressive illness

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Responses of plasma growth hormone and corticosteroids to insulin and arginine with or without prior administration of dexamethasone

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Suppression of Exercise-Induced Growth Hormone Release with Dexamethasone

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Pyridostigmine-induced growth hormone responses in healthy and depressed subjects: evidence for cholinergic supersensitivity in depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

A specific, non-chromatographic radioimmunoassay for human plasma cortisol

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Growth hormone response to growth hormone releasing hormone in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Growth hormone response to desmethylimipramine in depressed and suicidal adolescents

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Cholinergic REM sleep induction in atypical depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021

Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1002%2FHUP.470090302

7 January 2021